Epizyme (EPZM) Tops Q1 EPS by 6c

Epizyme (NASDAQ: EPZM) reported Q1 EPS of ($0.49), $0.06 better than the analyst estimate of ($0.55). Revenue for the quarter came in at $0 versus the consensus estimate of $210 million.

For earnings history and earnings-related data on Epizyme (EPZM) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30